Atezolimab İlişkili Ensefalopati
Referanslar
Pardoll D.M. The blockade of immune checkpoints in cancer immunotherapy. Nat. Rev. Cancer. 2012;12:252–264
Satake T, Maruki Y, Kubo Y. Atezolizumab-induced Encephalitis in a Patient with Hepatocellular Carcinoma: A Case Report and Literature Review. Intern Med.2022; 61: 2619–2623.
Ibrahim EY, Zhao WC, Mapuru HH and et al. Hope, Cure and Adverse Effects in Immunotherapy: Atezolizumab-Associated Encephalitis in Metastatic Small Cell Lung Cancer-A Case Report and Literature Review. Case Reports in Neurology, 2022, 14:366-371
Satake T, Maruki Y, Kubo Y. Atezolizumab-induced Encephalitis in a Patient with Hepatocellular Carcinoma: A Case Report and Literature Review. Intern Med.2022; 61: 2619–2623.
Ibrahim EY, Zhao WC, Mapuru HH and et al. Hope, Cure and Adverse Effects in Immunotherapy: Atezolizumab-Associated Encephalitis in Metastatic Small Cell Lung Cancer-A Case Report and Literature Review. Case Reports in Neurology, 2022, 14:366-371
Sayfalar
165-168
Gelecek
14 Haziran 2024
Telif Hakkı (c) 2024 Akademisyen Yayınevi Kitap Portalı
Lisans
LisansNasıl Atıf Yapılır
1.
Yıldız G. Atezolimab İlişkili Ensefalopati. Içinde: Bıçakcı Ş, Demir T, Bıçakcı YK, editörler. Olgularla Nörolojik Yoğun Bakım [Internet]. Türkiye: Akademisyen Yayınevi Kitap DOI Portalı; 2024 [a.yer 12 Temmuz 2026]. ss. 165-8. Erişim adresi: https://omp35.books.akademisyen.net/index.php/akya/catalog/book/3085/chapter/13024
